Japan Approves New Parkinson’s & Heart Disease Treatments
Japan Approves Groundbreaking Cell-Based Therapies for Parkinson’s Disease and Heart Condition Tokyo, Japan – In a landmark achievement for regenerative medicine, Japan has approved innovative cell-based therapies for both Parkinson’s disease and ischemic cardiomyopathy, a serious heart condition. The approvals, granted on March 6, 2026, mark the first time cell-based treatments utilizing induced pluripotent stem … Read more